PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Phillips DiPisa

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Basilea Pharmaceuticals, Inc. Appoints National Sales Director - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug
Basilea Pharmaceuticals, Inc. Appoints National Sales Director

 

NewswireToday - /newswire/ - Hingham, MA, United States, 2007/10/09 - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Phillips DiPisa, a retained executive search firm serving healthcare providers, managed care organizations, and life sciences firms, today announced that it has completed an executive search assignment for Basilea Pharmaceuticals, Inc.

Basilea Pharmaceuticals, Inc., a newly launched U.S. subsidiary of Switzerland's Basilea Pharmaceutica, hired Ken Farah as the National Sales Director. Phillips DiPisa led the search on behalf of Basilea Pharmaceuticals.

At Basilea, Farah will lead the company’s first sales team for Ceftobiprole, which is awaiting FDA approval to treat methicillin-resistant staff infections.

Farah has over 25 years of sales and sales management experience launching specialty anti-infective and oncology products in the hospital markets. Most recently, Farah was a Sales Director for Dendreon Corporation. Prior, he managed regions around the country for Ortho McNeil/Alza, where he helped build the specialty sales force for the ADHD drug Concerta.

Farah also served at ALZA, Sequus and Immunex, in capacities such as Regional Manager, Director of Strategic Oncology accounts and Oncology Account Executive. He began his career in sales at Lederle, where he rose to management in the hospital division and concentrated on antibiotic sales in the hospital marketplace.

Basilea Pharmaceutica Ltd. is a biopharmaceutical company focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea’s products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio, including three investigational phase III drugs of which two have shown positive pivotal phase III results.

Kevin Carroll was Phillips DiPisa’s associate responsible for this engagement.

About Phillips DiPisa

Phillips DiPisa (phillipsdipisa.com) recruits leaders for healthcare providers, managed care organizations, and life sciences firms. The firm’s roots are in Greater Boston – a historical center of medical innovation and excellence. Phillips DiPisa now serves clients along the East Coast and throughout the Midwest, and draws on a national pool of candidates.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Phillips DiPisa

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Basilea Pharmaceuticals, Inc. Appoints National Sales Director

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Beth Mills - PhillipsDiPisa.com 
781-740-9699 bamills[.]phillipsdipisa.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Phillips DiPisa securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Phillips DiPisa / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)